Evidence map›Paper›PMID 36936758›Full record

ArticleFrontiers in cellular and infection microbiology2023

An image-based high-content screening for compounds targeting

Ariane Honfozo, Rodrigue Houngue, Alexandre Vandeputte, Sébastien Dechavanne, Odilon Nouatin, Ménonvè Cynthia Atindehou, Lucie Ayi Fanou, Achille Massougbodji, Célia Dechavanne, Priscille Brodin and 1 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ariane HonfozoUniversité Paris Saclay, CNRS UMR 9198-CEA, Institute for Integrative Biology of the Cell (I2BC), Gif sur Yvette, France.
Rodrigue HoungueUniversité Paris Saclay, CNRS UMR 9198-CEA, Institute for Integrative Biology of the Cell (I2BC), Gif sur Yvette, France.
Alexandre VandeputteUniversité de Lille, CNRS UMR 9017, INSERM U 1019, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, CIIL - Center for Immunity and Infection of Lille, Lille, France.
Sébastien DechavanneUniversité de Paris Cité, IRD, MERIT, Paris, France.
Odilon NouatinInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Ménonvè Cynthia AtindehouLaboratoire de Biochimie et de Biologie Moléculaire, FAST/UAC, Cotonou, Benin.
Lucie Ayi FanouLaboratoire de Biochimie et de Biologie Moléculaire, FAST/UAC, Cotonou, Benin.
Achille MassougbodjiInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Célia DechavanneUniversité de Paris Cité, IRD, MERIT, Paris, France.
Priscille BrodinUniversité de Lille, CNRS UMR 9017, INSERM U 1019, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, CIIL - Center for Immunity and Infection of Lille, Lille, France.
Stanislas TomavoUniversité Paris Saclay, CNRS UMR 9198-CEA, Institute for Integrative Biology of the Cell (I2BC), Gif sur Yvette, France.
Centre National de la Recherche Scientifique · FRUniversité d'Abomey-Calavi · BJUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ParasitesToxoplasmaAnimalsEndosomesGreen Fluorescent ProteinsHumansPlasmodium falciparumProtozoan ProteinsGreen Fluorescent ProteinsProtozoan Proteinshigh-content screeningimage-based analysismalaria parasiterepurposing drugsROP1-mCherryTgSORT-GFPToxoplasma gondii

Identifiers

PMID36936758
PMCPMC10020723
OpenAlexW4323045807

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read6
measurements read61
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.